Global nuclear medicine community shares COVID-19 strategies and experiences

April 01, 2020

In an effort to provide safer working environments for nuclear medicine professionals and their patients, clinics across five continents have shared their approaches to containing the spread of COVID-19 in a series of editorials, published ahead of print in The Journal of Nuclear Medicine. This compilation of strategies, experiences and precautions is intended to support nuclear medicine clinics as they make decisions regarding patient care.

Clinicians from Africa, Asia, Australia, Europe and North America provided summaries of the steps their individual hospitals and clinics have taken to combat the COVID-19 pandemic. According to editorial author, Ken Herrmann, MD, MBA, chair of nuclear medicine at the University of Duisburg-Essen, Essen, Germany, the most common steps taken by clinics have been to triage patients upon arrival, reduce elective nuclear medicine studies, improve hygiene practices and establish rotations of medical personnel to create back-up teams should a staff member become infected.

For patients undergoing essential nuclear medicine procedures, incidental findings can suggest signs of COVID-19, according to editorial author Domenico Albano, MD, nuclear medicine physician at the University of Brescia and Spedali Civili Brescia in Italy. Reporting on local experience in a region with high COVID-19 prevalence, Albano and colleagues found six out of 65 asymptomatic PET/CT patients and one of 12 radioiodine patients showed signs of interstitial pneumonia. Five of the seven patients were confirmed to have COVID-19; the remaining two did not receive immediate testing but underwent quarantine and careful monitoring.

"Our observations show that it is mandatory for healthcare personnel to employ hygienic measures, minimize patient contact and optimize distance, and use protective equipment for general clinical services in regions with high COVID prevalence," said Albano. "It is also important to consider potential COVID-19 related findings during reading, and to report such findings to the patient and his referring physicians immediately, for appropriate action."

Of particular interest to the nuclear medicine community is the safety of performing ventilation/perfusion studies. "Previous literature has documented a small degree of leakage of the aerosol from the closed delivery system into the room with the potential for expired air and aerosolized secretions to contaminate personnel within the imaging suite," noted Lionel S. Zuckier, MD, MBA, FRCPC, editorial author and chief of the division of nuclear medicine at Montefiore Medical Center and Albert Einstein College of Medicine in Bronx, New York. "In addition, patients frequently cough following inhalation of the radiopharmaceutical, which may further expose nuclear medicine workers to aerosolized secretions."

Given these circumstances, ventilation/perfusion studies have the potential to result in aerosolized secretions that can contribute to the spread of COVID-19. Zuckier and colleagues recommend eliminating the ventilation portion from lung perfusion/ventilation scans to reduce the risk of spreading COVID-19.

Additional steps taken by clinics to combat the spread of COVID-19 include limiting or cancelling research studies and scheduling symptomatic patients needing essential studies for the end of the day (allowing for thorough cleaning after the study). Some clinics have conducted refresher courses in infection control management and basic emergency management, while others have stressed the need for kindness and consideration in this unprecedented time.

Concerns were also voiced by nuclear medicine clinics around the world regarding potential nuclear reactor production restrictions and international travel limitations. Strategies to tackle these issues are being addressed by nuclear medicine and molecular imaging society leadership worldwide.

"These are difficult times; none of us has ever experienced anything like the current pandemic," remarked Johannes Czernin, MD, JNM editor-in-chief and chief of the Ahmanson Translation Imaging Division at the David Geffen School of Medicine at the University of California, Los Angeles in California. "We thank the hundreds of thousands of health care workers worldwide who have not hesitated for a moment to come in and do their job at times of great personal risk. These are selfless people who help and support each other; cover for each other; volunteer to step in and up as needed."
-end-
These articles were made available online in April 2020 ahead of final publication.

Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.

SNMMI's COVID-19 Resource Center can be accessed at http://www.snmmi.org.

About the Society of Nuclear Medicine and Molecular Imaging

The Journal of Nuclear Medicine (JNM) is the world's leading nuclear medicine, molecular imaging and theranostics journal, accessed close to 10 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field.

JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging--precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit http://www.snmmi.org.

Society of Nuclear Medicine and Molecular Imaging

Related Nuclear Medicine Articles from Brightsurf:

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

Story tips: Shuffling atoms, thinning forests, fusion assembly and nuclear medicine
ORNL Story Tips: Shuffling atoms, thinning forests, fusion assembly and nuclear medicine.

Global nuclear medicine community shares COVID-19 strategies and experiences
In an effort to provide safer working environments for nuclear medicine professionals and their patients, clinics across five continents have shared their approaches to containing the spread of COVID-19 in a series of editorials, published ahead of print in The Journal of Nuclear Medicine.

Influence of the Journal of Nuclear Medicine jumps 25%
The Journal of Nuclear Medicine again ranks among the top 5 medical imaging journals in the world.

Nuclear medicine PSMA-targeted study offers new options for cancer theranostics worldwide
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) describes a new class of radiopharmaceuticals, named radiohybrids (rh), that offer a fresh perspective on cancer imaging and radioligand therapy (theranostics).

Nuclear medicine imaging monitors effectiveness of therapy for melanoma patients
Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome.

Prostate cancer radiotherapy more precisely targeted with nuclear medicine imaging
A nuclear medicine imaging procedure can pinpoint prostate cancer with superior accuracy, allowing more precisely targeted treatment, according to new research featured in the November 2018 issue of The Journal of Nuclear Medicine.

New nuclear medicine tracer will help study the aging brain
A new PET imaging radiotracer could help researchers understand neurodegenerative disease and the aging brain.

New nuclear medicine imaging method shows strong potential for cancer imaging
A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.

New nuclear medicine technique could help tackle brain disease
A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis.

Read More: Nuclear Medicine News and Nuclear Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.